[ Price : $8.95]
MAPS Public Benefit Corp. files what it calls the first NDA submission for a psychedelic-assisted therapy, MDMA (midomafetamine ca...[ Price : $8.95]
Trump-associated America First Legal files a lawsuit against FDA and HHS for illegally concealing government records related to th...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Peloton Therapeutics Welire...[ Price : $8.95]
FDA accepts for review a Phathom Pharmaceuticals NDA for Voquezna (vonoprazan) as a daily treatment for heartburn associated with ...[ Price : $8.95]
FDA issues a revised final guidance entitled Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Pro...[ Price : $8.95]
Former Decision Diagnostics CEO Keith Berman (Westlake Village, CA) pleads guilty to securities fraud, wire fraud, and obstruction...[ Price : $8.95]
FDA tells isotretinoin manufacturers that they must modify their iPLEDGE Risk Evaluation and Mitigation Strategy to minimize the b...[ Price : $8.95]
FDA accepts an Ascendis Pharma NDA resubmission for TransCon PTH (palopegteriparatide) for treating adults with hypoparathyroidism...